My Sanford Chart allows you secure online access to your personal health information and your child's health information. It's available anywhere you have internet access. There is no cost to you and registering is quick and simple.

Sign Up for My Sanford Chart
Study ID: Inc Research Cubist CDiff

Phase 3 Randomized Double Blinded Active Controlled study in Patients with Clostridium difficile infection


The purpose of this study is to find out if CB-183,315 (an antibiotic) rather than oral vancomycin is a better therapeutic agent for the treatment of CDAD (clostridium difficile associated diarrhea) in adults. This study will use the difference in clinical response rates at end-of-therapy (EOT) for results.

Fargo Region
Principal Investigator:
Paul Mariani MD
Phase III


Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list